Rakuten Medical, Inc., a global clinical-stage biotechnology company focused on developing and commercializing innovative oncology products for multiple indications, has announced the completion of a $166 million Series D preferred stock financing, including $75 million in new capital and the conversion of $91 million of convertible promissory notes, including accrued …
FullStory, the leader in digital experience intelligence (DXI), announced that it has raised $103 million in growth capital financing via Series D funding. The oversubscribed Series D round was led by Permira's growth fund, which backs leading tech-enabled and digital businesses. Additional investors include all existing institutional investors, including Kleiner …
Paxos, blockchain startup, raises $300 Million in Series D
